Regulus Therapeutics Inc. Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase

EX-10.3 4 ex-103xpaulgrintannualsala.htm EXHIBIT 10.3 Exhibit

Exhibit 10.3

Regulus Therapeutics Inc.

Paul C. Grint, M.D. Yearly Discretionary Base Salary Increase

The Board of Directors (the “Board”) of Regulus Therapeutics Inc., upon the recommendation of the Compensation Committee of the Board, approved the increase of Dr. Grint’s annual base salary to $545,900, effective January 1, 2017.